We are monitoring the impact of COVID-19 on Latin America Peptide Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2021
ID: 12052
Share on
Share on

Latin America Peptide Therapeutics Market Research Report – Segmented By Type, Application, Type of Manufacturers, Route of Administration, Synthesis Technology & Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) – Industry Analysis on Size, Share, Trends, COVID-19 Impact and Growth Forecast (2021 to 2026)

Pulished: August, 2021
ID: 12052
Pages: 100

Latin America Peptide Therapeutics Market Size (2021 to 2026)

The Latin American peptide therapeutics market is forecasted to grow at a prominent CAGR from 2021 to 2026.

The key factors driving the market's growth include the increased incidence of various disorders such as cancer, gastrointestinal disorders, central nervous system disorders, respiratory disorders, and others, as well as the availability and development of advanced drugs for treatment. In addition, the market's growth is also associated with increased investments in R&D for drug discovery and the presence of a strong product portfolio in the market. In addition, the increase in clinical trials in the market also boosts the Latin American peptide therapeutics market during the forecast period.

Since 2019, more than $ 3 billion has been invested in companies involved in developing various types of peptide drugs. In addition, the market is experiencing significant associative activity; recently, players in this industry signed several licensing agreements focused on the development and commercialization of drugs. Due to their proven pharmacological value, the demand for peptide drugs is undoubtedly expected to increase in the coming years.

The application of peptide therapeutics in cancer treatment has opened up a promising avenue for the future growth of the Latin American peptide therapeutics market. Advances in technology have been beneficial in reducing the overall costs involved in the production of peptide therapies. This has prompted manufacturers and suppliers to pioneer new ways of making peptide therapies and tackling long and complex peptide chains. The radical shift towards hybrid technologies to reduce the strain on resources is likely to boost the short term of the Latin American peptide therapeutics market.

The Latin American peptide therapeutics market is expected to be hampered by the low chemical and physical stability of natural peptides and their limited half-life in circulating plasma. Additionally, since the peptide drugs are administered by injection, low oral availability and poor penetration of intestinal mucosa are expected to limit market growth in the near future.

Impact of COVID-19 on the Latin American peptide therapeutics market:

According to the research paper published in Nature Cancer, the COVID-19 pandemic is expected to have disrupted the spectrum of cancer care, including delayed diagnoses, treatment, and discontinuation of clinical trials aimed at developing drugs for effective therapies for cancer treatment, in which peptide therapeutics for the treatment of cancer are no exception. Therefore, the Latin American market studied is expected to be significantly affected during the pandemic.

This research report on the Latin American peptide therapeutics market has been segmented and sub-segmented into the following categories:

By Type:

  • Generic
  • Innovative

By Application:

  • Metabolic
  • Cardiovascular Disorder
  • Respiratory
  • GIT
  • Anti-infection
  • Pain
  • Dermatology
  • CNS
  • Renal
  • Others

By Type of Manufacturers:

  • In-house
  • Outsourced

By Route of Administration:

  • Parenteral Route
  • Oral Route
  • Pulmonary
  • Mucosal
  • Others

By Synthesis Technology:

  • Solid Phase Peptide Synthesis (SPPS)
  • Liquid Phase Peptide Synthesis (LPPS)
  • Hybrid Technology

By Country:

  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Rest of Latin America

Geographically, the Brazilian peptide therapeutics market is expected to dominate the Latin American market throughout the forecast period. The market's growth is driven by factors such as increasing awareness levels related to peptide therapies, the growing need for diagnostics for cancer and other diseases, and the growing biotechnology industry.

Contract Manufacturing Organizations (CMOs) that provide end-to-end services to biotech and pharmaceutical companies are getting a lot of attention because they provide a better manufacturing and fulfillment experience. Peptide therapy market players are placing more emphasis on outsourcing drug manufacturing to CMOs to reduce operating expenses. The manufacturing of peptide therapies offers limited space for players to develop distinctive strategies to secure a competitive advantage. In addition, rising contract manufacturing allows market players to add technical resources to their existing business models.

The high prevalence of cancer and the increasing incidence rate of new cancer cases are expected to drive the market in Mexico during the forecast period. On the other hand, other peptide therapeutic drugs recently introduced or in advanced stages of clinical trials are expected to retain a significant share of the global peptide therapy market at the end of the forecast period. Additionally, the peptide therapeutics market in Argentina is expected to grow significantly during the forecast period. The rise of biotechnology companies and increasing healthcare spending by government authorities, the increasing prevalence of cancer and nervous system disorders are some of the factors that are expected to drive demand for Latin American peptide therapeutics in the future.

KEY MARKET PLAYERS:

Some of the key players operating in the Latin American peptide therapeutics market profiled in this report are Eli Lilly and Company, Amgen, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Ever Neuro Pharma GmbH, Takeda Pharmaceutical Company Limited, AstraZeneca PLC, GlaxoSmithKline plc, Novo Nordisk A/S., Novartis AG, Zealand Pharma AG, AmbioPharm Inc., Bachem Holding AG, PolyPeptide Group, Sanofi SA, Amylin Pharmaceuticals, CirclePharma, Inc., PeptiDream Inc., Apitope Technology, Arch NioPartners, and Galena Biopharmaceuticals.

  1. Introduction                                                          
    1. Market Definition                                               
    2. Scope of the report                                            
    3. Study Assumptions                                            
    4. Base Currency, Base Year and Forecast Periods                                                     
  2. Research Methodology                                                                    
    1. Analysis Design                                                   
    2. Research Phases                                                 
      1. Secondary Research                                       
      2. Primary Research                              
      3. Data Modelling                                 
      4. Expert Validation                              
    3. Study Timeline                                                    
  3. Report Overview                                                                 
    1. Executive Summary                                           
    2. Key Inferences                                                  
  4. Market Dynamics                                                                
    1. Impact Analysis                                                   
      1. Drivers                                  
      2. Restraints                              
      3. Opportunities                                    
    2. Regulatory Environment                                                  
    3. Technology Timeline & Recent Trends                                                      
  5. Competitor Benchmarking Analysis                                                             
    1. Key Player Benchmarking                                                
      1. Market share analysis                                    
      2. Products/Service                              
      3. Regional Presence                            
    2. Mergers & Acquisition Landscape                                                
    3. Joint Ventures & Collaborations                                                  
  6. Market Segmentation                                                                       
    1. Peptide Therapeutics Market, By Type
      1. Generic
      2. Innovative
      3. Market Size Estimations & Forecasts (2021-2026)                               
      4. Y-o-Y Growth Rate Analysis                                         
      5. Market Attractiveness Index                                       
    2. Peptide Therapeutics Market, By Application                                  
      1. Metabolic
      2. Cardiovascular Disorder
      3. Respiratory
      4. GIT
      5. Anti-infection
      6. Pain
      7. Dermatology
      8. CNS
      9. Renal
      10. Others
      11. Market Size Estimations & Forecasts (2021-2026)                               
      12. Y-o-Y Growth Rate Analysis                                         
      13. Market Attractiveness Index       
    3. Peptide Therapeutics Market, By Type of Manufacturers 
      1. In-house
      2. Outsourced
      3. Market Size Estimations & Forecasts (2021-2026)                               
      4. Y-o-Y Growth Rate Analysis                                         
      5. Market Attractiveness Index       
    4. Peptide Therapeutics Market, By Route of Administration
      1. Parenteral Route
      2. Oral Route
      3. Pulmonary
      4. Mucosal
      5. Others
      6. Market Size Estimations & Forecasts (2021-2026)                               
      7. Y-o-Y Growth Rate Analysis                                         
      8. Market Attractiveness Index       
    5. Peptide Therapeutics Market, By Synthesis Technology
      1. Solid Phase Peptide Synthesis (SPPS)
      2. Liquid Phase Peptide Synthesis (LPPS)
      3. Hybrid Technology
      4. Market Size Estimations & Forecasts (2021-2026)                               
      5. Y-o-Y Growth Rate Analysis                                         
      6. Market Attractiveness Index       
  7. Geographical Landscape                                                                  
    1. Latin America                                                      
      1. By Country                                         
        1. Brazil                   
        2. Argentina                         
        3. Mexico                
        4. Rest of Latin America                   
  8. Key Player Analysis                                                             
    1. Eli Lilly and Company
      1. Business Description                                      
      2. Products/Service                              
      3. Financials                             
      4. SWOT Analysis                                  
      5. Recent Developments                                    
      6. Analyst Overview                              
    2. Amgen, Inc.
    3. Pfizer, Inc.
    4. Bristol-Myers Squibb Company
    5. Ever Neuro Pharma GmbH
    6. Takeda Pharmaceutical Company Limited
    7. AstraZeneca PLC
    8. GlaxoSmithKline plc
    9. Novo Nordisk A/S.
    10. Novartis AG
    11. Zealand Pharma AG
    12. AmbioPharm Inc.
    13. Bachem Holding AG
    14. PolyPeptide Group
    15. Sanofi SA
    16. Amylin Pharmaceuticals
    17. CirclePharma, Inc.
    18. PeptiDream Inc.
    19. Apitope Technology
    20. Arch NioPartners
    21. Galena Biopharmaceuticals
  9. Market Outlook & Investment Opportunities
  10. Appendix                                               
    1. List of Tables
    2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of product and end-user along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Latin America Peptide Therapeutics Market, By Type, From 2021 to 2026 (USD Billion)
  2. Latin America Generic Market, By Region, From 2021 to 2026 (USD Billion)
  3. Latin America Innovative Market, By Region, From 2021 to 2026 (USD Billion)
  4. Latin America Peptide Therapeutics Market, By Application, From 2021 to 2026 (USD Billion)
  5. Latin America Metabolic Market, By Region, From 2021 to 2026 (USD Billion)
  6. Latin America Cardiovascular Disorder Market, By Region, From 2021 to 2026 (USD Billion)
  7. Latin America Respiratory Market, By Region, From 2021 to 2026 (USD Billion)
  8. Latin America GIT Market, By Region, From 2021 to 2026 (USD Billion)
  9. Latin America Anti-infection Market, By Region, From 2021 to 2026 (USD Billion)
  10. Latin America Pain Market, By Region, From 2021 to 2026 (USD Billion)
  11. Latin America Dermatology Market, By Region, From 2021 to 2026 (USD Billion)
  12. Latin America CNS Market, By Region, From 2021 to 2026 (USD Billion)
  13. Latin America Renal Market, By Region, From 2021 to 2026 (USD Billion)
  14. Latin America Others Market, By Region, From 2021 to 2026 (USD Billion)
  15. Latin America Peptide Therapeutics Market, By Type of Manufacturers, From 2021 to 2026 (USD Billion)
  16. Latin America In-house Market, By Region, From 2021 to 2026 (USD Billion)
  17. Latin America Outsourced Market, By Region, From 2021 to 2026 (USD Billion)
  18. Latin America Peptide Therapeutics Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  19. Latin America Parenteral Route Market, By Region, From 2021 to 2026 (USD Billion)
  20. Latin America Oral Route Market, By Region, From 2021 to 2026 (USD Billion)
  21. Latin America Pulmonary Market, By Region, From 2021 to 2026 (USD Billion)
  22. Latin America Mucosal Market, By Region, From 2021 to 2026 (USD Billion)
  23. Latin America Others Market, By Region, From 2021 to 2026 (USD Billion)
  24. Latin America Peptide Therapeutics Market, By Synthesis Technology, From 2021 to 2026 (USD Billion)
  25. Latin America Solid Phase Peptide Synthesis (SPPS) Market, By Region, From 2021 to 2026 (USD Billion)
  26. Latin America Liquid Phase Peptide Synthesis (LPPS) Market, By Region, From 2021 to 2026 (USD Billion)
  27. Latin America Hybrid Technology Market, By Region, From 2021 to 2026 (USD Billion)
  28. Brazil Peptide Therapeutics Market, By Type, From 2021 to 2026 (USD Billion)
  29. Brazil Peptide Therapeutics Market, By Application, From 2021 to 2026 (USD Billion)
  30. Brazil Peptide Therapeutics Market, By Type of Manufacturers, From 2021 to 2026 (USD Billion)
  31. Brazil Peptide Therapeutics Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  32. Brazil Peptide Therapeutics Market, By Synthesis Technology, From 2021 to 2026 (USD Billion)
  33. Argentina Peptide Therapeutics Market, By Type, From 2021 to 2026 (USD Billion)
  34. Argentina Peptide Therapeutics Market, By Application, From 2021 to 2026 (USD Billion)
  35. Argentina Peptide Therapeutics Market, By Type of Manufacturers, From 2021 to 2026 (USD Billion)
  36. Argentina Peptide Therapeutics Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  37. Argentina Peptide Therapeutics Market, By Synthesis Technology, From 2021 to 2026 (USD Billion)
  38. Mexico Peptide Therapeutics Market, By Type, From 2021 to 2026 (USD Billion)
  39. Mexico Peptide Therapeutics Market, By Application, From 2021 to 2026 (USD Billion)
  40. Mexico Peptide Therapeutics Market, By Type of Manufacturers, From 2021 to 2026 (USD Billion)
  41. Mexico Peptide Therapeutics Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  42. Mexico Peptide Therapeutics Market, By Synthesis Technology, From 2021 to 2026 (USD Billion)
  43. Rest of Latin America Peptide Therapeutics Market, By Type, From 2021 to 2026 (USD Billion)
  44. Rest of Latin America Peptide Therapeutics Market, By Application, From 2021 to 2026 (USD Billion)
  45. Rest of Latin America Peptide Therapeutics Market, By Type of Manufacturers, From 2021 to 2026 (USD Billion)
  46. Rest of Latin America Peptide Therapeutics Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  47. Rest of Latin America Peptide Therapeutics Market, By Synthesis Technology, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample